Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

[Rectal bleeding during pregnancy].

de Jonge HJ, Oosterwijk PR, Meijssen M, Flierman A.

Ned Tijdschr Geneeskd. 2014;158(4):A6758. Dutch.

PMID:
24447671
2.

[Calcium suppletion for patients who use gastric acid inhibitors: calcium citrate or calcium carbonate?].

de Jonge HJ, Gans RO, Huls G.

Ned Tijdschr Geneeskd. 2012;156(34):A4343. Review. Dutch.

PMID:
22914054
3.

Stromal interaction essential for vascular endothelial growth factor A-induced tumour growth via transforming growth factor-β signalling.

Weidenaar AC, ter Elst A, Kampen KR, Meeuwsen-de Boer TG, de Jonge HJ, Scherpen FJ, den Dunnen WF, Kamps WA, de Bont ES.

Br J Cancer. 2011 Dec 6;105(12):1856-63. doi: 10.1038/bjc.2011.460. Epub 2011 Nov 1.

4.

Gene expression profiling in the leukemic stem cell-enriched CD34+ fraction identifies target genes that predict prognosis in normal karyotype AML.

de Jonge HJ, Woolthuis CM, Vos AZ, Mulder A, van den Berg E, Kluin PM, van der Weide K, de Bont ES, Huls G, Vellenga E, Schuringa JJ.

Leukemia. 2011 Dec;25(12):1825-33. doi: 10.1038/leu.2011.172. Epub 2011 Jul 15.

PMID:
21760593
5.

Prognostic impact of white blood cell count in intermediate risk acute myeloid leukemia: relevance of mutated NPM1 and FLT3-ITD.

de Jonge HJ, Valk PJ, de Bont ES, Schuringa JJ, Ossenkoppele G, Vellenga E, Huls G.

Haematologica. 2011 Sep;96(9):1310-7. doi: 10.3324/haematol.2011.040592. Epub 2011 May 23.

6.

Gene expression profiling in acute myeloid leukaemia.

de Jonge HJ, Huls G, de Bont ES.

Neth J Med. 2011 Apr;69(4):167-76. Review.

7.

Repression of vascular endothelial growth factor expression by the runt-related transcription factor 1 in acute myeloid leukemia.

Ter Elst A, Ma B, Scherpen FJ, de Jonge HJ, Douwes J, Wierenga AT, Schuringa JJ, Kamps WA, de Bont ES.

Cancer Res. 2011 Apr 1;71(7):2761-71. doi: 10.1158/0008-5472.CAN-10-0402. Epub 2011 Mar 29.

8.

Vascular Endothelial Growth Factor A isoform mRNA expression in pediatric acute myeloid leukemia.

Kruizinga RC, de Jonge HJ, Kampen KR, Walenkamp AM, de Bont ES.

Pediatr Blood Cancer. 2011 Feb;56(2):294-7. doi: 10.1002/pbc.22783.

PMID:
20981743
9.

High VEGFC expression is associated with unique gene expression profiles and predicts adverse prognosis in pediatric and adult acute myeloid leukemia.

de Jonge HJ, Valk PJ, Veeger NJ, ter Elst A, den Boer ML, Cloos J, de Haas V, van den Heuvel-Eibrink MM, Kaspers GJ, Zwaan CM, Kamps WA, Löwenberg B, de Bont ES.

Blood. 2010 Sep 9;116(10):1747-54. doi: 10.1182/blood-2010-03-270991. Epub 2010 Jun 3.

10.

Paradoxical down-regulation of p16 mRNA with advancing age in acute myeloid leukemia.

de Jonge HJ, Woolthuis CM, de Bont ES, Huls G.

Aging (Albany NY). 2009 Oct 23;1(11):949-53.

11.

AML at older age: age-related gene expression profiles reveal a paradoxical down-regulation of p16INK4A mRNA with prognostic significance.

de Jonge HJ, de Bont ES, Valk PJ, Schuringa JJ, Kies M, Woolthuis CM, Delwel R, Veeger NJ, Vellenga E, Löwenberg B, Huls G.

Blood. 2009 Oct 1;114(14):2869-77. doi: 10.1182/blood-2009-03-212688. Epub 2009 Aug 10.

12.

A new perspective on transcriptional system regulation (TSR): towards TSR profiling.

Fehrmann RS, de Jonge HJ, Ter Elst A, de Vries A, Crijns AG, Weidenaar AC, Gerbens F, de Jong S, van der Zee AG, de Vries EG, Kamps WA, Hofstra RM, Te Meerman GJ, de Bont ES.

PLoS One. 2008 Feb 20;3(2):e1656. doi: 10.1371/journal.pone.0001656.

13.

Endogenous vascular endothelial growth factor-C expression is associated with decreased drug responsiveness in childhood acute myeloid leukemia.

de Jonge HJ, Weidenaar AC, Ter Elst A, Boezen HM, Scherpen FJ, Bouma-Ter Steege JC, Kaspers GJ, Goemans BF, Creutzig U, Zimmermann M, Kamps WA, de Bont ES.

Clin Cancer Res. 2008 Feb 1;14(3):924-30. doi: 10.1158/1078-0432.CCR-07-1821.

14.

Addition of PTK787/ZK 222584 can lower the dosage of amsacrine to achieve equal amounts of acute myeloid leukemia cell death.

Weidenaar AC, de Jonge HJ, Fidler V, ter Elst A, Meeuwsen-de Boer T, Douwes J, Bouma-ter Steege JC, Hählen K, Kamps WA, de Bont ES.

Anticancer Drugs. 2008 Jan;19(1):45-54.

PMID:
18043129
15.

Evidence based selection of housekeeping genes.

de Jonge HJ, Fehrmann RS, de Bont ES, Hofstra RM, Gerbens F, Kamps WA, de Vries EG, van der Zee AG, te Meerman GJ, ter Elst A.

PLoS One. 2007 Sep 19;2(9):e898.

16.

Sirenomelia ('mermaid').

de Jonge HJ, Los JA, Knipscheer RJ, Frensdorf EL.

Eur J Obstet Gynecol Reprod Biol. 1984 Sep;18(1-2):85-93.

PMID:
6500152
17.

Takayasu's or pulseless disease in pregnancy.

de Jonge HJ, Knipscheer RJ, Weigel HM.

Eur J Obstet Gynecol Reprod Biol. 1983 Jan;14(4):241-9. Review.

PMID:
6131846

Supplemental Content

Loading ...
Support Center